These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8471616)

  • 1. Formation of DNA-protein cross-links in mammalian cells by levuglandin E2.
    Murthi KK; Friedman LR; Oleinick NL; Salomon RG
    Biochemistry; 1993 Apr; 32(15):4090-7. PubMed ID: 8471616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levuglandin E2 crosslinks proteins.
    Iyer RS; Ghosh S; Salomon RG
    Prostaglandins; 1989 Apr; 37(4):471-80. PubMed ID: 2762557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levuglandin E2-protein adducts in human plasma and vasculature.
    Salomon RG; Subbanagounder G; O'Neil J; Kaur K; Smith MA; Hoff HF; Perry G; Monnier VM
    Chem Res Toxicol; 1997 May; 10(5):536-45. PubMed ID: 9168251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the lysyl adducts of prostaglandin H-synthases that are derived from oxygenation of arachidonic acid.
    Boutaud O; Brame CJ; Chaurand P; Li J; Rowlinson SW; Crews BC; Ji C; Marnett LJ; Caprioli RM; Roberts LJ; Oates JA
    Biochemistry; 2001 Jun; 40(23):6948-55. PubMed ID: 11389610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin endoperoxides 21. Covalent binding of levuglandin E2 with proteins.
    Salomon RG; Jirousek MR; Ghosh S; Sharma RB
    Prostaglandins; 1987 Nov; 34(5):643-56. PubMed ID: 3481092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation and stability of pyrrole adducts in the reaction of levuglandin E2 with proteins.
    DiFranco E; Subbanagounder G; Kim S; Murthi K; Taneda S; Monnier VM; Salomon RG
    Chem Res Toxicol; 1995; 8(1):61-7. PubMed ID: 7703368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levuglandin E2 inhibits mitosis and microtubule assembly.
    Murthi KK; Salomon RG; Sternlicht H
    Prostaglandins; 1990 Jun; 39(6):611-22. PubMed ID: 2115185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoprotein.
    Salomon RG; Sha W; Brame C; Kaur K; Subbanagounder G; O'Neil J; Hoff HF; Roberts LJ
    J Biol Chem; 1999 Jul; 274(29):20271-80. PubMed ID: 10400646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophilic levuglandin E2-protein adducts bind glycine: a model for protein crosslinking.
    Jirousek MR; Murthi KK; Salomon RG
    Prostaglandins; 1990 Aug; 40(2):187-203. PubMed ID: 2217833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of covalent adducts of nucleosides and DNA formed by reaction with levuglandin.
    Carrier EJ; Amarnath V; Oates JA; Boutaud O
    Biochemistry; 2009 Nov; 48(45):10775-81. PubMed ID: 19824699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage recognition of LDL modified by levuglandin E2, an oxidation product of arachidonic acid.
    Hoppe G; Subbanagounder G; O'Neil J; Salomon RG; Hoff HF
    Biochim Biophys Acta; 1997 Jan; 1344(1):1-5. PubMed ID: 9022751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation of low-density lipoproteins produces levuglandin-protein adducts.
    Salomon RG; Subbanagounder G; Singh U; O'Neil J; Hoff HF
    Chem Res Toxicol; 1997 Jul; 10(7):750-9. PubMed ID: 9250408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of mitomycin C with mammalian DNA detected by alkaline elution.
    Dorr RT; Bowden GT; Alberts DS; Liddil JD
    Cancer Res; 1985 Aug; 45(8):3510-6. PubMed ID: 3926301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity.
    Plooy AC; van Dijk M; Lohman PH
    Cancer Res; 1984 May; 44(5):2043-51. PubMed ID: 6538808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of DNA lesions and cytotoxicity induced by calcium chromate in human, mouse, and hamster cell lines.
    Sugiyama M; Wang XW; Costa M
    Cancer Res; 1986 Sep; 46(9):4547-51. PubMed ID: 3731109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total Synthesis Confirms the Molecular Structure Proposed for Oxidized Levuglandin D
    Cheng YS; Yu W; Xu Y; Salomon RG
    J Nat Prod; 2017 Feb; 80(2):488-498. PubMed ID: 28195470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts.
    Roberts LJ; Salomon RG; Morrow JD; Brame CJ
    FASEB J; 1999 Jul; 13(10):1157-68. PubMed ID: 10385607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure.
    Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N
    J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levuglandins and isolevuglandins: stealthy toxins of oxidative injury.
    Salomon RG
    Antioxid Redox Signal; 2005; 7(1-2):185-201. PubMed ID: 15650407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway.
    Boutaud O; Brame CJ; Salomon RG; Roberts LJ; Oates JA
    Biochemistry; 1999 Jul; 38(29):9389-96. PubMed ID: 10413514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.